Trial Profile
Phase I/II first-in-man trial of CYT 007 TNF Qb in patients with plaque psoriasis.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 18 Aug 2011
Price :
$35
*
At a glance
- Drugs CYT 007 TNFQb (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Cytos Biotechnology
- 31 May 2007 New trial record.